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Abstract 
Background: Few studies have investigated the interaction of bioadhesives with biologic tissues for veterinary 
application. Hence, this study evaluates the mucoadhesive property and vaccine delivery properties of polymers from 
phytogenic origin. Gums from Cedrela odorata and Khaya senegalensis were harvested, purified, dried and compressed 
into 500 mg tablets individually and in combined ratios. The time taken for these tablets, placed on freshly excised 
(5 × 5 cm) trachea and duodenal tissues of cattle, chicken, pig, sheep and goat and fastened to the basket end of 
a tablet dissolution machine probe set at 50 rev/min in a phosphate buffer 6.8 pH at 37 °C, to fall off the tissue was 
the peak adhesion time (PAT). Gum with best PAT was combined with Newcastle disease vaccine and the procedure 
repeated. Haemagglutination assay (HA) was conducted on the gum polymer-vaccine mix with gum and vaccine 
individually as controls.
Results: On intestinal and trachea tissues, Cedrela gum polymer averagely had prolonged PAT (≈1 h 30 min and 1 h 
respectively) while average PAT values of Khaya gums followed the same trend but too transient PAT (≈6 and 0.3 min 
respectively). However on combination, Cedrela–Khaya polymer mix (1:1) was best on chicken, cattle and sheep 
trachea and intestinal tissues (PAT of 1 h 30 min and 2 h 24 min respectively). On combination with vaccine, the PAT 
of the gums reduced slightly on cattle and sheep tissues while other animal tissue showed varied results. The HA 
results showed the gum polymer boosted the HA property of the vaccine (Log 105), when compared to vaccine alone 
(Log 104).
Conclusion: Hence, mucoadhesives from phytogenic sources have potential for non-invasive vaccine application.
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Background
Over the past few decades, improving delivery system 
to optimize drug and vaccine responses has become a 
research focus. As extensive research is being carried out 
on discoveries of new drugs so also studies to advance 
delivery system especially along the non-invasive routes- 
the mucosal route are being conducted (Sumanjali and 
Sellappan 2013). This was reflected with the global rev-
enue for advanced drug delivery system estimated to be 
$181.9 billion in 2013 and projected to be about $212.8 
billion in 2018 at 3.2  % annual growth (PRNewswire, 
Sept. 2, 2014).
The mucosal route is the most extensive and first line 
of barrier most pathogens penetrates in other to estab-
lish an infection (Saroj and Bala 2010). It is also the most 
accessible and non-invasive route for drug and vaccine 
delivery. Studies also showed that generating protec-
tive mucosal antibodies through parenteral vaccination 
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is difficult while obtaining protective mucosal as well 
as parenteral immunity by inoculating antigen by the 
mucosal route is often possible (Bye et  al. 1984). This 
gives an edge to the mucosal route over invasive paren-
teral procedures. Hence the adaptive development of 
strong immunoprotective mechanisms such as extensive 
continuous antigenic sampling and induction, immune 
exclusion and cross protection across mucosal surfaces 
has made enhancement of these mechanisms of interest 
to researchers.
However, unpredictable absorptive or antigenic 
response along this route due to dynamic interplay of 
physical and chemical mechanisms of homeostatic bal-
ance has made this route less preferable to other routes. 
This was evident in the reports of Sabri et  al. (2013), 
where protective immune response was achieved with 
the use of intranasal recombinant Mannheimia hemo-
lytica vaccine against caprine pneumonia in boer goats.
Hence in view of the potential inherent in the explo-
ration of mucosal immunity, studies aimed at enhanc-
ing xenobiotic absorption and modulation of antigenic 
responses to vaccines along this route is needed. This 
could be achieved through development and explora-
tion of bioadhesives polymers to enhance bioadhesion to 
mucosal surfaces such as skin, nasal, buccal, vaginal, and 
rectal i.e. mucoadhesion which is term used to define the 
interfacial force interactions between polymeric materi-
als and mucosal tissues (Odeniyi et al. 2015).
When compared to mineral oil or alum-compound 
widely employed as components of most parenteral vac-
cines, mucoadhesives could adsorb temporarily to mucus 
membranes thus decreasing the transit time, potentially 
forms a temporary depot system for gradual continuous 
antigen release, activation and recruitment of antigen 
presenting cells (APCs) with subsequent formation of 
high affinity antibodies (Khurana et al. 2010; Mohan et al. 
2013).
Mucoadhesion mainly occurs in three contiguous 
stages which begins by an intimate contact between the 
mucoadhesive polymer and the mucus layer, polymer 
macromolecular penetration of the mucus layer and ulti-
mately molecular interaction by secondary non-cova-
lent bonds. These bonds have being reported to occur 
through physical or mechanical interaction through the 
entanglement of the adhesive material and extensive 
mucus chains as well as secondary chemical interactions. 
The latter may be due to electrostatic or hydrophobic 
interactions, hydrogen or covalent bonding as well as dis-
persion forces. Several theories have been proposed to 
explain these fundamental mechanism(s) of attachment. 
Examples of such are wetting, electronic, adsorption, and 
diffusion and fracture theories (Dominique and Gilles 
1997; Globodanka and Duncan 1997).
Though the application of mucoadhesive polymers 
from natural sources dates back to the mid-19th century 
when gum tragacanth and dental adhesive powders were 
combined to form a delivery vehicle for penicillin appli-
cation, synthetic polymers with risks of mucosal irrita-
tion have been developed and widely explored (Adriaens 
et al. 2003; Ameye et al. 2005). Examples of plants from 
which mucoadhesive products have been explored 
includes locust bean, Xanthum and Okra for controlled 
release (Xiaohong et  al. 2003; Kalu et  al. 2007; Beneke 
et al. 2009; Rohit et al. 2014), karaya, acacia, and cashew 
gums as suspending, emulsifying and dental adhesives 
(Munday and Philip 2000; Ahmed and Al-Ghazawi 2005; 
Shefter 2009), Khaya gum as binding agents (Odeku and 
Itiola 2003).
Marine sea weed gums, alginates and carrageenan are 
also examples adhesive polymers from marine while 
other non-phytogenic polymers explored include Tuft-
sin, an immunostimulatory peptide; chitosan, chitin, hya-
luronic acid and chondroitin sulphate (Rohit et al. 2014; 
Gao et al. 2015).
Although plants presents with abundant reservoir of 
these natural polymers known as gums and mucilages 
which had gained extensive applications such as in food 
and drug preparations, the usefulness of these polymers 
in veterinary medicine have not been fully researched. 
Few studies have elucidated on the potential of Cedrela 
and Khaya gums as a candidate for drug delivery (Odeniyi 
et al. 2013, 2015) and as a possible binder in drug prepa-
rations respectively. They have neither been individually 
or in combination explored with respect to veterinary 
vaccine delivery. The aim of the present preliminary 
study is to evaluate ex vivo, the interaction of these gum 
gels with biologic tissues with respect to possible applica-
tion for non-invasive methods of vaccine delivery in vet-
erinary subjects.
Diverse techniques with different approaches have 
being proposed for both ex  vivo and in  vivo evaluation 
of bioadhesive strength of most polymeric substances. 
Most ex vivo techniques such as the Wilhelmy plate tech-
nique, Electromagnetic force transducer have been used 
to evaluate tensile stress while adhesion tests based on 
measurement of the force required to separate two poly-
mer coated glass slides with a film of mucus sandwiched 
between have been used to evaluate shear stress. Such 
was the design of a flow chamber method by Mikos and 
Peppas (1990). Other approaches such as the rheological 
method (Prabhu et al. 2010; Riley et al. 2001) and the vis-
cometric method (Hassan and Gallo 1990) have also been 
used to evaluate in vivo behavior of mucoadhesive poly-
mers and quantify mucin-polymer bioadhesive strength 
respectively. However, in this study, due to limited 
resources, a tablet dissolution machine was adaptively 
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used to evaluate the interaction between the gum poly-
mer and mucosal tissue surfaces. This attempts to simu-
late the interplay of factors which plays out between 
mucosal surface and the mucoadhesive polymer under an 
in vivo condition.
Methods
Quantification of mucin‑polymer bioadhesive strength
A tablet dissolution machine (Copley dissolution appara-
tus) (Fig. 1c) was adaptively used to quantify the mucin-
polymer bioadhesive strength. This is a modification to 
the shear stress measurement technique (Prabhu et  al. 
2010).
This machine was used to quantify the mucin-polymer 
adhesive strength by determining the peak adhesion time 
in a hydrated environment (physiologic buffer, pH and 
temperature) while the revolution of the machine probe 
provided a measure of the shear stress of the gum on the 
biological tissue (Odeniyi et al. 2013).
Determination of peak adhesion time
The peak adhesion time was the time it takes for a 
mucoadhesive material compressed into tablet to detach 
from an animal tissue mounted on the probe of the dis-
solution machine under physiological conditions which 
simulates the interplay of in vivo condition.
Fig. 1 a–d for Ex-vivo evaluation of the mucoadhesive properties of Cedrela odorata and Khaya senegalensis gums with possible applications for 
veterinary vaccine delivery. a Hydraulic tableting machine. b Tablets of different polymer ratios. c Tablet dissolution machine. d Tablet on tissue 
(inset) Immersed in phosphate buffer and subsequently in water bath at 37 °C
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Gum preparation
Cedrela and Khaya gums were extracted from incised stems 
of Cedrela odorata and Khaya senegalensis trees respec-
tively. The gums were validated to be from Cedrela odorata 
and Khaya senegalensis (Desv.) A. Juss tress at the Depart-
ment of Botany Herbarium, University of Ibadan with ref-
erence numbers UIH-22378 and UIH-22415, respectively. 
They were purified at the Department of Pharmaceutics 
and Industrial Pharmacy, Faculty of Pharmacy, Univer-
sity of Ibadan, using methods described by Odeniyi et  al. 
(2015). Briefly, the exudates were hydrated in 0.5:95.5 (v/v) 
CHCl3-water mixtures for 5 days with intermittent stirring; 
extraneous materials were removed by straining through 
a muslin cloth. The gums were precipitated from solution 
with absolute ethanol which were then filtered, washed 
with diethyl ether, and dried in hot air oven at 40  °C for 
18 h. The gum precipitates were pulverized using a labora-
tory blender and sieved. 500 mg of each gum were meas-
ured and compressed into tablets (Fig. 1b) at a pressure of 
1 kg using a Hydraulic tableting machine (Fig. 1a).
Tissue preparation
About 5 cm × 5 cm each of freshly excised trachea and 
duodenal tissues from five domestic animals namely Cat-
tle, Chicken, Pig, Goat and Sheep were collected from the 
abattoir and used for the experiment.
Experimental procedure
The freshly excised and trimmed animal tissues were 
mounted on the basket end attached to the probe of the 
Tablet dissolution machine (Fig. 1c). The tissues were fas-
tened to the basket end with an elastic band and the gum 
tablet placed on the mucosal surface carefully. This was 
then lowered into a beaker containing phosphate buffer 
solution of pH 6.8. The beaker sits within a large water 
bath with temperature set at 37  °C. The machine was 
then set at 50 revolutions per minute which mimics the 
in vivo physiologic fluid, pH, temperature and peristaltic 
movement of contractile smooth muscles.
The time it took for a gum tablet to fall off the tissue is 
recorded as the peak adhesion time (PAT) (Fig. 1d). This 
adhesion time is a reflection of the strength of interaction 
of the gum molecules with the mucosa layer of the tissues 
under simulated in  vivo conditions. This procedure was 
conducted in triplicates on the same tissues from differ-
ent domestic animals as stated above. The average peak 
adhesion time with standard deviation was evaluated 
using Microsoft Excel software package.
Haemagglutination assay
The gum with the best PAT, was then combined with 
lyophilized Newcastle disease vaccine (Indovax; dos-
age of 200 birds containing ≥106 ED50) in the ratio 2:2:1 
(Cedrela:Khaya:Vaccine) under cold chain, processed 
into tablets and the procedure above repeated for all 
domestic animal tissues stated earlier.
Haemagglutination assay was also carried out at the 
Avian Research Unit, Department of Veterinary Medi-
cine, and University of Ibadan on the gum polymer-vac-
cine mix with gum alone and vaccine alone as controls. 
Protocols from the Laboratory were also employed for 
the test. Briefly, the gum polymer vaccine mix was dis-
solved in 8  ml of normal saline; 50  μl of normal saline 
was dispensed into each microtitre well while 50 μl of the 
antigenic solution (gum-vaccine mix) was added into the 
first well in each row. With the micropipette, the content 
of the first row was mixed and 50 μl transferred into the 
second row of well. The procedure was repeated serially 
for all rows of well with the last 50 μl dispensed off. 50 μl 
of 0.5  % chicken red blood cell was then added to each 
well, mixed briefly together on a micro-shaker (Flow Lab-
oratories, GmbH Diezstrabe 10, 5300, Bonn 3) and left 
on the bench for 30 min. The last dilution which shows 
Haemagglutination was taken as the titer of the antigen.
Furthermore, checkerboard dilution was also car-
ried out on gum polymer mix sample that gave the best 
PAT. This dilution were then split in two sets, a part was 
heat inactivated in water bath at 56 °C for 30 min while 
the other part was left on the bench. HA assay was then 
repeated for the gum polymer mix alone to ascertain the 
lowest dilution with the least agglutinating property.
Results
The peak adhesion time (PAT) for Cedrela odorata and 
Khaya senegalensis gum tablets are given in Table 1.






 Trachea 94.3 ± 23.6 0.55 ± 0.05
 Intestine 117.8 ± 39.8 4.63 ± 1.91
Chicken
 Trachea 111.1 ± 15.6 0.20 ± 0.10
 Intestine 55.5 ± 33.0 10.07 ± 2.93
Pig
 Trachea 51.1 ± 20.0 0.07 ± 0.05
 Intestine 76.7 ± 11.5 8.33 ± 2.32
Goat
 Trachea 8.2 ± 6.0 0.20 ± 0.00
 Intestine 106.7 ± 15.3 3.10 ± 0.87
Sheep
 Trachea 22.6 ± 7.9 0.17 ± 0.06
 Intestine 131.7 ± 72.5 3.10 ± 0.87
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From Table  1, Cedrela gum was strongest on the intes-
tine of all animal species except the chicken. Hence from 
the above, Cedrela gum will be best suitable as a vehicle for 
vaccines or drugs delivered along the gut mucosa in most 
domestic animals except in the chicken where it appears 
to be more adaptable along the airway mucosal e.g. spray 
vaccines. The PAT of Khaya gum was also strongest on 
intestine and therefore would be best adapted as a delivery 
vehicle for gut vaccines and drugs than for the airway. How-
ever, when compared with Cedrela gum, Khaya gum adhe-
sion action time appears too transient while that of Cedrela 
appears moderate. Therefore a combination of both gums at 
varying ratios was done to determine the effect of Cedrela 
gum polymer on Khaya gum polymer adhesion time.
Both gum polymers were combined in ratios 1:1, 1:3 
compressed at the same pressure as was the individual 
polymers and PAT evaluated. The results obtained are 
given in Table 2.
From Table 2 PAT of Cedrela-Khaya 1:1 gum polymer 
mix increased considerably on all trachea tissues except 
pig and chicken when compared to either gum polymer 
singly. Also a considerable increase was observed on the 
intestine mucosa from all the animals used compared to 
both gums singly. Hence, the use of both gum combined 
in equal ratio as a delivery vehicle would be best preferred 
for oral and spray based vaccines and drugs as opposed 
to the gums singly except with few exceptions. While the 
1:3 gum polymer mix improved on trachea tissues but 
not as 1:1 gum polymer mix on gut mucosa which makes 
it a potential candidate for drugs and vaccines along that 
route. However, on the trachea mucosa, the adhesion 
force was weak when compared to the 50 % each combi-
nation ratio or Cedrela gum alone but better than Khaya 
alone
Overall the gum polymers and their combinations 
adhesion action in each animal tissue from highest to the 
least are given as follows in Table 3. 
On all trachea tissues, the peak adhesion strength was 
divided between Cedrela Khaya 1:3 gum polymer mix, 
Cedrela alone and Cedrela Khaya 1:1 gum polymer mix. 
While on all intestinal tissues, the peak adhesion strength 
was divided between Cedrela Khaya 1:3, Cedrela Khaya 
1:1 combinations and Cedrela alone. Overall however, 
on cattle, chicken and sheep tissues, Cedrela-Khaya (1:1) 
mix had highest PAT; on goat tissues, Cedrela-Khaya 
(1:3) mix while either Cedrela-Khaya (1:1) mix or Cedrela 
alone would be adaptively reliable for pig tissues.
On combination with vaccine, the PAT of the gums 
reduced slightly on cattle and sheep tissues while other 
animal tissue showed varied results. Although the vac-
cine used was primarily a poultry vaccine and the result 
obtained on tissues of other species might not be reflec-
tion of what could be obtained with specie specific vac-
cines, it however gave a rough idea of the interaction of 
the gum polymer mix with vaccines on mucosa surfaces 
especially with regards to poultry species.
Haemagglutination assay results showed the gum poly-
mer boosted the HA property of the vaccine (Log  105), 
when compared to vaccine alone (Log  104). Although 
the gum polymer mix alone also showed HA property 
(Log 105) equivalent to the gum polymer mix and vaccine 
combination (Table 4).
Due to hemagglutinating property, the results of the 
checkerboard dilution conducted on both bench and 
heat inactivated gum polymer sets are presented below in 
Table 5.
From Table 5 above, the heat inactivated gum mix had 
lower heamagglutinating property than the bench at both 
neat and 1:2 dilutions. However, at 1:4, 1:6, 1:8 dilutions, 
the titer was the same. Hence 1:8 bench dilution with the 
least agglutinating titer was recommended as a delivery 
vaccine vehicle in an in vivo model study.
Discussion
Current research in vaccine development focuses on 
development of vaccine protocols requiring single or 
multiple non-invasive administration, since the major 
disadvantage of many currently available vaccines is that 
most are applied through parenteral routes and repeated 
administrations are required (Saroj and Bala 2010) 
Repeated vaccine application is especially needful in 
Nigeria where Newcastle disease (ND), a per acute, acute 
and sometimes subclinical contagious disease of poultry 
Table 2 Peak adhesion time for  Cedrela-Khaya gum poly-






 Trachea 185.00 ± 35.00 35.53 ± 7.82
 Intestine 246.67 ± 84.10 180.33 ± 17.90
Chicken
 Trachea 58.30 ± 19.26 9.37 ± 6.44
 Intestine 156.10 ± 17.66 167.1 ± 23.92
Pig
 Trachea 21.00 ± 14.30 11.33 ± 6.55
 Intestine 156.10 ± 17.67 94.80 ± 16.63
Goat
 Trachea 22.33 ± 6.97 24.87 ± 2.48
 Intestine 118.3 ± 67.08 93.53 ± 72.78
Sheep
 Trachea 168.27 ± 133.78 10.83 ± 5.22
 Intestine 156.77 ± 23.69 162.00 ± 17.44
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is endemic (Health et al. 1999; Oladele et al. 2002). Mor-
tality from frequent outbreaks often reaches 100  % 
(Alders and Spradbrow 2001).
The main routes of entry of many poultry viral diseases 
including Newcastle disease which affect respiratory, 
gastrointestinal and nervous systems are that of mucosal 
route (respiratory through inhalation, intestinal through 
ingestion) (Whiteman and Bickford 1983). Hence a 
potent means of defense might be by improving antigenic 
induction with subsequent improved effector mecha-
nisms along these routes. This pattern was verified in the 
reports of Emikpe et al. (2013) where pathological evalu-
ation of goats vaccinated intranasally showed no pneu-
monic lung lesion compared to the observed lesions in 
the subcutaneously, intramuscularly vaccinated groups. 
Ezeasor et al. (2013, 2014) also reported improved lym-
phoproliferative responses when haematological changes 
associated with intranasal and parenteral routes of vac-
cination against PPR virus was evaluated in West African 
dwarf goats.
In poultry, although vaccine delivery along these 
mucosal routes are already in use, but limiting factors 
such as unpredictable or limited immune responses, 
shortened protection interval, endemicity of the disease 
leading to frequent outbreaks have resulted in dishar-
monized vaccine protocol among farmers (Okwor et  al. 
2010; Oluwole et  al. 2012). These reasons coupled with 
search for non-invasive methods of vaccine administra-
tion which could evoke better protective responses led to 
the development and standardization of mucoadhesives 
as vehicle for vaccine delivery.
From this study, going by the interaction of mucoadhe-
sives (gum gels) from the phytogenic sources used, there 
is a rapid and prolonged adherence to the mucosa sur-
face. This was observed in the gum polymer combination 
which could be attributed to a possible synergistic effect 
of the phytogenic mucoadhesives on the tissues.
Also, the viscoelastic properties exhibited by the phyto-
genic mucoadhesives in hydrated environment was good 
as revealed by the strong interaction with mucin on the 
mucosal tissue with minimal variation and breakdown 
at the mucoadhesive mucus interface of adhesion. This 
showed a good macromolecular interpenetration effect 
to form a stable hydrated gel by bonds (such as weak van 
der Waals and hydrogen bonding) and secondary inter-
actions (glycoproteins). The breakdown observed at the 
mucus layer as opposed to the mucoadhesive-mucus 
Table 3 Summary of Peak adhesion time of phytogenic polymer used from highest to lowest on trachea and intestines 
of domestic animals
S/no Animal Tissue Highest → lowest
1 Cattle Trachea Ced: Kha1:3 Ced: Kha1:1 Ced. 100 % Khaya 100 %
Intestine Ced: Kha 1:1 Ced: Kha 1:3 Ced. 100 % Khaya 100 %
2 Chicken Trachea Ced. 100 % Ced: Kha 1:1 Ced: Kha 1:3 Khaya 100 %
Intestine Ced: Kha 1:3 Ced: Kha 1:1 Ced. 100 % Khaya 100 %
3 Pig Trachea Ced. 100 % Ced: Kha 1:1 Ced: Kha 1:3 Khaya 100 %
Intestine Ced: Kha 1:1 Ced: Kha 1:3 Ced. 100 % Khaya 100 %
4 Goat Trachea Ced: Kha 1:3 Ced: Kha 1:1 Ced. 100 % Khaya 100 %
Intestine Ced. 100 % Ced: Kha 1:3 Ced: Kha 1:1 Khaya 100 %
5 Sheep Trachea Ced: Kha 1:1 Ced. 100 % Ced: Kha 1:3 Khaya 100 %
Intestine Ced: Kha 1:3 Ced: Kha 1:1 Ced. 100 % Khaya 100 %
Table 4 Gum polymer mix and  vaccine combination hae-
magglutination assay results
S/no Test Antigenic titer (Log2)
1. Vaccine 4
2. Vaccine + Gum (Ced:Khy) Combination 5
3. Gum (Ced + Khy) alone 5
4. Gum (Cedrela) 5
5. Gum (Khaya) 5
Table 5 Gum polymer mix, checkerboard dilution 
and haemagglutination assay results




1. Gum mix (neat) 5 4
2. Gum mix (1:2 dilu-
tion)
4 4
3. Gum mix (1:4 dilu-
tion)
3 4
4. Gum mix (1:8 dilu-
tion)
2 2
5. Gum (1:16 dilution) 2 2
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interface plane of adhesion showed that mucoadhesives 
from these phytogenic sources are strong enough to 
cause a prolonged and stable interaction with the mucus 
layer of mucosal surfaces. Thus facilitating a prolonged 
time for continuous antigenic presentation, stimulation 
and response (Parthasarathy et  al. 2011) and would be 
well adaptable for an in vivo study.
Further, the interference by hydrodynamic conditions, 
pH and vaccine components were moderate, especially for 
the latter. This places the mucoadhesive as a good candi-
date for vaccine vehicle especially in veterinary subjects as 
it showed good inter-penetration with vaccine antigens, 
retention of mucoadhesive property and boost in Haemag-
glutination property of the gum polymer-vaccine mix. This 
latter activity is a desirable factor in the design of an ideal 
adjuvant which can possibly provide an immunopotenti-
ating response to vaccines under in vivo conditions. Also, 
the observed haemagglutination activity of these mucoad-
hesives could be due to the presence of lectins which is 
reported to be abundant in plants and its products. These 
ubiquitous highly specific sugar-binding proteins also have 
mitogenic, antibacterial, antifungal, antiviral as well as 
cytotoxic activities (Ingale and Hivrale 2013).
Therefore mucoadhesives from phytogenic origin 
shows potential as bioadhesive delivery vehicle for vac-
cines in veterinary subjects, however, these claims need 
to be validated under in vivo conditions.
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